19,752 Shares in Cognex Corporation $CGNX Bought by Savant Capital LLC

Savant Capital LLC bought a new position in Cognex Corporation (NASDAQ:CGNX) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 19,752 shares of the scientific and technical instruments company’s stock, valued at approximately $627,000.

Several other hedge funds have also recently added to or reduced their stakes in CGNX. Nordea Investment Management AB lifted its stake in shares of Cognex by 148.5% during the second quarter. Nordea Investment Management AB now owns 7,075,772 shares of the scientific and technical instruments company’s stock valued at $223,594,000 after acquiring an additional 4,228,729 shares during the period. Scientech Research LLC boosted its stake in Cognex by 93.8% during the 1st quarter. Scientech Research LLC now owns 29,828 shares of the scientific and technical instruments company’s stock worth $890,000 after acquiring an additional 14,434 shares during the last quarter. World Investment Advisors bought a new stake in Cognex in the second quarter valued at approximately $204,000. Teacher Retirement System of Texas raised its holdings in Cognex by 7.9% in the second quarter. Teacher Retirement System of Texas now owns 52,502 shares of the scientific and technical instruments company’s stock worth $1,665,000 after purchasing an additional 3,862 shares during the period. Finally, Pallas Capital Advisors LLC bought a new stake in shares of Cognex in the second quarter worth about $535,000. Institutional investors own 88.12% of the company’s stock.

Cognex Stock Performance

Shares of NASDAQ:CGNX opened at $36.77 on Friday. The firm has a market cap of $6.16 billion, a PE ratio of 57.45 and a beta of 1.52. Cognex Corporation has a 52 week low of $22.67 and a 52 week high of $49.76. The firm’s fifty day moving average is $44.27 and its 200-day moving average is $37.96.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings data on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.06. Cognex had a return on equity of 8.26% and a net margin of 11.33%.The company had revenue of $264.00 million for the quarter, compared to analyst estimates of $261.86 million. During the same period in the previous year, the firm earned $0.20 earnings per share. The firm’s quarterly revenue was up 18.0% on a year-over-year basis. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. Sell-side analysts forecast that Cognex Corporation will post 0.61 EPS for the current year.

Cognex Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 28th. Investors of record on Thursday, November 13th will be given a dividend of $0.085 per share. The ex-dividend date of this dividend is Thursday, November 13th. This is an increase from Cognex’s previous quarterly dividend of $0.08. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.9%. Cognex’s payout ratio is 53.13%.

Insider Activity

In other Cognex news, Director Robert Willett sold 6,704 shares of the business’s stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $49.51, for a total value of $331,915.04. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Sheila Marie Dipalma sold 2,000 shares of the stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $45.03, for a total transaction of $90,060.00. Following the completion of the sale, the executive vice president owned 6,582 shares in the company, valued at $296,387.46. This represents a 23.30% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 10,706 shares of company stock valued at $512,065. Company insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. JPMorgan Chase & Co. assumed coverage on Cognex in a research note on Monday, September 15th. They set a “neutral” rating and a $45.00 target price for the company. Truist Financial set a $45.00 price target on Cognex and gave the company a “hold” rating in a research note on Wednesday, October 8th. KeyCorp reaffirmed an “overweight” rating and set a $50.00 price objective on shares of Cognex in a research report on Friday, October 31st. Robert W. Baird set a $45.00 price target on Cognex in a research report on Friday, October 31st. Finally, UBS Group restated a “buy” rating and set a $58.00 target price on shares of Cognex in a report on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $46.20.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.